National Cancer Institute; Notice of Meeting, 59814 [2020-20995]
Download as PDF
<![CDATA[
59814
Federal Register / Vol. 85, No. 185 / Wednesday, September 23, 2020 / Notices
Dated: September 17, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–20991 Filed 9–22–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Building Interdisciplinary Research
Careers in Women’s Health (BIRCWH)
Annual Meeting, and the Specialized
Centers of Research Excellence
(SCORE) Annual Meeting Keynote
Address
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Building
Interdisciplinary Research Careers in
Women’s Health (BIRCWH) Annual
Meeting, held virtually December 14,
2020, sponsored by the Office of
Research on Women’s Health (ORWH),
will focus on mentoring young
investigators, present their research
findings, and celebrate the 20th
anniversary of the program. The
Specialized Centers of Research
Excellence on Sex Differences (SCORE)
Annual Meeting keynote address, held
virtually on December 16, 2020,
sponsored by ORWH, will offer the
perspective of an editor of The Lancet
on sex differences research and the
health of women. Both of these
programs are signature programs created
by ORWH in partnership with a number
of National Institutes of Health (NIH)
institutes and centers.
DATES: The BIRCWH Annual Meeting
will be held virtually on December 14,
2020, from 10:00 a.m. to 5:00 p.m. EST.
The SCORE Annual Meeting keynote
address will be held virtually on
December 16, 2020, from 10:45 a.m. to
11:30 a.m. EST.
ADDRESSES: The BIRCWH Annual
Meeting and the SCORE Annual
Meeting keynote address are virtual
events. Event information can be found
on the ORWH website: https://
orwh.od.nih.gov/about/newsroom/
events.
FOR FURTHER INFORMATION CONTACT: For
information concerning these meetings,
see the ORWH website, https://
orwh.od.nih.gov/about/newsroom/
events, or contact Lamont Williams,
Communications Director, Office of
Research on Women’s Health, 6707
Democracy Boulevard, Suite 400,
Bethesda, MD 20817, telephone: 301–
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:13 Sep 22, 2020
Jkt 250001
402–1770; email: ORWHComms@
od.nih.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In
accordance with 42 U.S.C. 287d, of the
Public Health Service Act, as amended
and in keeping with the 30th
anniversary of ORWH putting science to
work for the health of women across
NIH, these meetings offer enlightening
virtual presentations on health research,
scientific advances on the influence of
sex and gender in health and disease,
and progress for women in biomedical
careers.
Celebrating its 20th year, BIRCWH is
an institutional mentored careerdevelopment grant program connecting
junior faculty, known as BIRCWH
Scholars, to senior faculty with shared
interest in women’s health and sex
differences research. The BIRCWH
Annual Meeting brings BIRCWH
Scholars and faculty together to share
research and experiences. The BIRCWH
4th Ruth L. Kirschstein Memorial
Lectureship will focus on the
importance of and improvements to be
made in mentoring young investigators.
The meeting will also include
presentations on research findings by
several leading BIRCWH Scholars.
Patricia E. Molina, M.D., Ph.D., Richard
Ashman Professor and Head,
Department of Physiology, Louisiana
State University School of Medicine,
will deliver a special Innovation talk to
celebrate the 20th anniversary of the
BIRCWH program and close the session.
SCORE is the only NIH cooperative
agreement program supporting diseaseagnostic research on sex differences.
Each SCORE program serves as a
national resource for translational
research, at multiple levels of analysis,
to identify the role of biological sex
differences in the health of women. At
this year’s SCORE Annual Meeting,
Jocalyn Clark, Ph.D., Executive Editor,
The Lancet, will present the keynote
address: ‘‘Sex Differences Research and
the Health of Women: An Editor’s
Perspective.’’
The BIRCWH Annual Meeting and the
SCORE Annual Meeting keynote
address are free and open to the public.
National Institutes of Health
SUPPLEMENTARY INFORMATION:
Date: September 17, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2020–21030 Filed 9–22–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
The meeting will be held as a virtual
meeting and open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Name of Committee: Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
Date: October 14, 2020.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: Ongoing and new activities at the
Frederick National Laboratory for Cancer
Research.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Contact Person: Caron A. Lyman, Ph.D.,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W126,
Bethesda, MD 20892–9750, 240–276–6348,
lymanc@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/fac/fac.htm,
where an agenda, instructions for access, and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 17, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–20995 Filed 9–22–20; 8:45 am]
BILLING CODE 4140–01–P
Frm 00080
Fmt 4703
Sfmt 4703
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 85, Number 185 (Wednesday, September 23, 2020)]
[Notices]
[Page 59814]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20995]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Frederick National
Laboratory Advisory Committee to the National Cancer Institute.
The meeting will be held as a virtual meeting and open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting, should notify the Contact Person listed below in advance of
the meeting. The meeting will be videocast and can be accessed from the
NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Frederick National Laboratory Advisory
Committee to the National Cancer Institute.
Date: October 14, 2020.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: Ongoing and new activities at the Frederick National
Laboratory for Cancer Research.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Contact Person: Caron A. Lyman, Ph.D., Executive Secretary,
National Cancer Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W126, Bethesda, MD 20892-9750, 240-276-
6348, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/fac/fac.htm, where an
agenda, instructions for access, and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 17, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-20995 Filed 9-22-20; 8:45 am]
BILLING CODE 4140-01-P
